Health Dialog Appoints Robert Mandel as New Chief Executive Officer

Physician Executive Continues Company’s Blueprint for Growth, Focus on Total Population Health

BOSTON--(BUSINESS WIRE)--Health Dialog today announced that Robert Mandel, MD, MBA has been named the new company CEO. Mandel will take the reins from James Tugendhat, Health Dialog’s current CEO, who will be based in London and lead the creation and delivery of Bupa’s global healthcare partnership strategy.

“We congratulate Robert and James on their achievements to date and their new leadership accountabilities”

Dr. Mandel joined Health Dialog in May 2011 as Executive Vice President for Market and Business Development, leading the company through a major strategic reorganization late last year. His in-depth knowledge and understanding of the healthcare industry led to innovations in the company’s service delivery model, expanding Total Population Health management solutions to new markets.

Prior to joining Health Dialog, Dr. Mandel served as the Senior Vice President of Health Care Services at Blue Cross Blue Shield of Tennessee. Earlier, he held the role of Vice President of Health Care Services at Blue Cross Blue Shield of Massachusetts.

“Health Dialog is building upon its strong care management and analytics foundation to help broad populations improve and maintain their health and coordinate their care. It is an honor to become the CEO of such a dynamic and meaningful organization,” said Dr. Mandel. “The services we provide empower people to make the healthcare decisions that are right for them. In doing so, we advance progress on the issues of cost and quality, which are fundamental challenges to a sustainable healthcare system.”

As part of the leadership transition, James Tugendhat will relocate to Bupa’s corporate center in London, where he will lead the creation and delivery of Bupa’s global healthcare partnership strategy.

“Robert Mandel has a true vision for Health Dialog in line with our mission to empower people around Shared Decision Making,” said James Tugendhat. “His keen insight into the industry, as well as his unwavering commitment to our business and the individuals we serve will ensure Health Dialog grows and develops even further under his new leadership. Robert has been my partner in leading the business over the past couple of years and I look forward to continuing our work together.”

“We congratulate Robert and James on their achievements to date and their new leadership accountabilities,” said Bupa Chief Executive Officer Stuart Fletcher. “Health Dialog is an exciting and critical part of Bupa, offering Total Population Health services and solutions that are integral to our mission to provide quality healthcare services and to serve millions more people as part of our Bupa 2020 vision.”

About Health Dialog:

Health Dialog Services Corporation is a leading provider of Total Population Health management solutions rooted in the model of Shared Decision Making, an approach where patients and clinicians work together to discuss treatment options based on evidence, and that reflect the patient's own values and preferences. The firm is a private, wholly-owned subsidiary of Bupa, a global provider of healthcare services. Company offerings include health coaching for medical decisions; population analytic solutions; and consulting services. Health Dialog helps individuals participate in their own healthcare decisions, develop more effective relationships with their physicians, and live healthier, happier lives. For more information please visit www.healthdialog.com.